Key points of critical review and adaptation of clinical guidelines of the European Federation of Internal Medicine for the treatment of hospitalized patients with hyperglycemia

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Diabetes mellitus (DM) is one of the most common socially significant chronic infectious diseases. Treatment of hyperglycemia in hospitalized patients with previously known or newly diagnosed DM or with stress hyperglycemia is a complex and challenging task. Experts from the European Federation of Internal Medicine (EFIM) analyzed and critically assessed existing clinical guidelines concerning issues related to hyperglycemia in hospitalized patients of different age, on the basis of which recommendations for the management of this category of patients were developed. There were suggested 75 recommendations, focused on 5 common clinical scenarios: target glycemic values, management of patients with comorbidities and elderly patients with low level of consciousness or dementia receiving irregular meals or parenteral/enteral nutrition, special cases of hyperglycemia (stress hyperglycemia, treatment with corticosteroids, fasting) and hypoglycemic therapy upon discharge from the hospital. This article is devoted to the discussion of the key provisions of the critical review of EFIM guidelines.

Full Text

Restricted Access

About the authors

Vera N. Larina

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia (Pirogov University)

Email: larina_vn@rsmu.ru
ORCID iD: 0000-0001-7825-5597
SPIN-code: 3674-9620

MD, Dr. Sci. (Medicine), professor, head of the Department of outpatient therapy of the Institute of clinical medicine

Russian Federation, Moscow

Valentin A. Kokorin

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia (Pirogov University); RUDN University

Author for correspondence.
Email: kokorin_va@pfur.ru
ORCID iD: 0000-0001-8614-6542
SPIN-code: 9772-2288

MD, Dr. Sci. (Medicine), associate professor, head of the Department of hospital therapy with a courses in endocrinology, hematology and clinical laboratory diagnostics of the Medical institute; professor of the Department of hospital therapy named after academician P.E. Lukomsky of the Institute of clinical medicine

Russian Federation, Moscow; Moscow

Natalya A. Suvorova

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia (Pirogov University)

Email: natalia-suvorova@inbox.ru
ORCID iD: 0000-0001-5959-6759
SPIN-code: 2582-3709

MD, PhD (Medicine), associate professor of the Department of hospital therapy named after academician P.E. Lukomsky of the Institute of clinical medicine

Russian Federation, Moscow

Svetlana N. Kislaya

RUDN University

Email: kislaya_sn@pfur.ru
ORCID iD: 0000-0002-2523-5944
SPIN-code: 3999-6060

MD, PhD (Medicine), associate professor of the Department of hospital therapy with a courses in endocrinology, hematology and clinical laboratory diagnostics of the Medical institute

Russian Federation, Moscow

Viktor I. Lunev

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia (Pirogov University)

Email: sandvit@yandex.ru
ORCID iD: 0000-0001-9002-7749
SPIN-code: 6618-7536

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia (Pirogov University)

Russian Federation, Moscow

References

  1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. PMID: 34879977. PMCID: PMC11057359. https://doi.org/10.1016/j.diabres.2021.109119
  2. Дедов И.И., Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А., Сазонова Д.В., Мокрышева Н.Г. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023;26(2):104–123. [Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Sazonova DV, Mokrysheva NG. Diabetes mellitus in the Russian Federation: Dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Sakharnyy diabet = Diabetes Mellitus. 2023;26(2):104–123 (In Russ.)]. EDN: DVDJWJ. https://doi.org/10.14341/dm13035
  3. Шестакова М.В., Викулова О.К., Железнякова А.В., Кутакова Д.В., Исаков М.А., Мокрышева Н.Г. Сахарный диабет у лиц пожилого возраста: клинико-эпидемиологические характеристики всероссийской когорты пациентов старше 65 лет. Сахарный диабет. 2024;27(6):504–519. [Shestakova MV, Vikulova OK, Zheleznyakova AV, Kutakova DV, Isakov MA, Mokrysheva NG. Diabetes mellitus in the elderly: Clinical and epidemiological characteristics of the all-Russian cohort of diabetic patients over 65 years. Sakharnyy diabet = Diabetes Mellitus. 2024;27(6):504–519. (In Russ.)]. EDN: LCAMJW. https://doi.org/10.14341/dm13261
  4. Дедов И.И., Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А., Кутакова Д.В., Мокрышева Н.Г. Эпидемиология и ключевые клинико-терапевтические показатели сахарного диабета в Российской Федерации в разрезе стратегических целей Всемирной организации здравоохранения. Сахарный диабет. 2025;28(1):4–17. [Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Kutakova DV, Mokrysheva NG. Epidemiology and key clinical and therapeutic indicators of diabetes mellitus in Russian Federation according to the World Health Organization’s strategy goals. Sakharnyy diabet = Diabetes Mellitus. 2025;28(1):4–17 (In Russ.)]. EDN: UQHMTC. https://doi.org/10.14341/dm13292
  5. Всемирная организация здравоохранения. Семьдесят пятая сессия Всемирной ассамблеи здравоохранения. Женева, 22–28 мая 2022 г. Резолюции и решения. Приложения. Женева. 2022. Доступ: https://apps.who.int/gb/ebwha/pdf_files/WHA75-REC1/A75_REC1_Interactive_ru.pdf (дата обращения – 17.04.2025). [World Health Organization. Seventy-fifth session of the World Health Assembly. Geneva, May 22–28, 2022. Resolutions and decisions. Applications. Geneva. 2022. URL: https://apps.who.int/gb/ebwha/pdf_files/WHA75-REC1/A75_REC1_Interactive_ru.pdf (date of access – 17.04.2025) (In Russ.)].
  6. Tyagi S, Koh V, Koh GC-H, Low LL, Lee ES. Defining and measuring multimorbidity in primary care in Singapore: Results of an online Delphi study. PLoS One. 2022;17(12):e0278559. PMID: 36455000. PMCID: PMC9714819. https://doi.org/10.1371/journal.pone.0278559
  7. Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z et al. Multimorbidity of cardiometabolic diseases: Prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9(3):e024476. PMID: 30833320. PMCID: PMC6443196. https://doi.org/10.1136/bmjopen-2018-024476
  8. Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW et al. Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabet Res Clin Pract. 2020;162:108086. PMID: 32068099. https://doi.org/10.1016/j.diabres.2020.108086
  9. Florencio RB, de Araujo Fonseca LG, da Silva VFD, Lima ÍNDF, Gualdi LP. Diabetes mellitus hospitalization and mortality rate according to a national database in Brazil: A longitudinal study. BMC Public Health. 2021;21(1):403. PMID: 33632201. PMCID: PMC7908752. https://doi.org/10.1186/s12889-021-10438-z
  10. Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BAJ et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. 2014;40(7):973–80. PMID: 24760120. https://doi.org/10.1007/s00134-014-3287-7
  11. Салухов В.В., Минаков А.А., Шарыпова Т.Г., Кононова А.А., Сурхаева В.А. Нарушения углеводного обмена и их исходы в отдаленном периоде у госпитализированных пациентов с COVID-19. Сахарный диабет. 2022;25(5):468–476. [Salukhov VV, Minakov AA, Sharypova TG, Kononova AA, Surkhaeva VA. Сarbohydrate metabolism disorders and their outcomes in the long-term period in hospitalized patients with COVID-19. Sakharnyy diabet = Diabetes Mellitus. 2022;25(5):468–476 (In Russ.)]. EDN: DQCKAF. https://doi.org/10.14341/dm12856
  12. Barbu E, Mihaila A, Filippi A, Stoenescu A, Ciortan L, Butoi E et al. Stress, hyperglycemia, and insulin resistance correlate with neutrophil activity and impact acute myocardial infarction outcomes. Cureus. 2024;16(7):e63731. PMID: 39100008. PMCID: PMC11295428. https://doi.org/10.7759/cureus.63731
  13. Hussain S, Moorthy M. Managing hyperglycaemia in inpatients. Clin Med. 2021;21(4):e332–e336. PMID: 35192473. PMCID: PMC8313212. https://doi.org/10.7861/clinmed.2021-0367
  14. Gianchandani RY, Iyengar JL, Butler SO, Chames MC, Raymond E, Miller BS et al. Inpatient diabetes guideline for adult non-critically ill patients. Ann Arbor (MI): Michigan Medicine University of Michigan. 2020. PMID: 32931166.
  15. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al. on behalf of the American Diabetes Association. 16. Diabetes care in the hospital: Standards of care in diabetes-2023. Diabet Care. 2023;46(Suppl 1):S267–S278. PMID: 36507644. PMCID: PMC9810470. https://doi.org/10.2337/dc23-S016
  16. Aberer F, Hochfellner DA, Sourij H, Mader JK. A practical guide for the management of steroid induced hyperglycaemia in the hospital. J Clin Med. 2021;10(10):2154. PMID: 34065762. PMCID: PMC8157052. https://doi.org/10.3390/jcm10102154
  17. Lesniak W, Morbidoni L, Dicker D, Marín-Leon I.; EFIM. Clinical practice guidelines adaptation for internists – an EFIM methodology. Eur J Intern Med. 2020;77:1–5. PMID: 32482600. https://doi.org/10.1016/j.ejim.2020.05.016
  18. Uyaroglu OA, Ruza I, Skrha J, Patoulias D, Bevc S, Bojadjiev BI et al. Treatment of hospitalized patient with hyperglycemia: An EFIM critically appraised and adapted guideline. Eur J Intern Med. 2025;132:27–36. PMID: 39658400. https://doi.org/10.1016/j.ejim.2024.11.018
  19. Моргунов Л.Ю. Гипергликемия критических состояний у пациентов без диабета. Эндокринология: новости, мнения, обучение. 2018;7(2):14–25. [Morgunov LYu. Hyperglycemia in critically ill conditions in patients without diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie = Endocrinology: News, Opinions, Training. 2018;7(2):14–25 (In Russ.)]. EDN: XXSEIH. https://doi.org/10.24411/2304-9529-2018-12001
  20. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473–78. PMID: 18540046. PMCID: PMC2742903. https://doi.org/10.2337/dc08-0545
  21. Buchleitner AM, Martínez-Alonso M, Hernandez M, Sola I, Mauricio D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev. 2012;(9):CD007315. PMID: 22972106. https://doi.org/10.1002/14651858.CD007315.pub2
  22. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67. PMID: 11794168. https://doi.org/10.1056/nejmoa011300
  23. Griesdale DEG, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A et al. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–27. PMID: 19318387. PMCID: PMC2665940. https://doi.org/10.1503/cmaj.090206
  24. Gunst J, Debaveye Y, Güiza F, Dubois J, De Bruyn A, Dauwe D et al.; TGC-Fast Collaborators. Tight blood-glucose control without early parenteral nutrition in the ICU. N Engl J Med. 2023;389(13):1180–90. PMID: 37754283. https://doi.org/10.1056/nejmoa2304855
  25. Umpierrez GE. Glucose control in the ICU. N Engl J Med. 2023;389(13):1234–37. PMID: 37754290. https://doi.org/10.1056/nejme2309442
  26. Low Wang CC, Draznin B. Practical approach to management of inpatient hyperglycemia in select patient populations. Hosp Pract (1995). 2013;41(2):45–53. PMID: 23680736. https://doi.org/10.3810/hp.2013.04.1025
  27. Клинические рекомендации. Сахарный диабет 2 типа у взрослых. Российская ассоциация эндокринологов. Рубрикатор клинических рекомендаций Минздрава России. 2022. ID: 290_2. Доступ: https://cr.minzdrav.gov.ru/preview-cr/290_2 (дата обращения – 17.04.2025). [Clinical guidelines. Type 2 diabetes mellitus in adults. Russian Association of Endocrinologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2022. ID: 290_2. URL: https://cr.minzdrav.gov.ru/preview-cr/290_2 (date of access – 17.04.2025) (In Russ.)].
  28. Rojas-Henao NA, Garcia-Rivera M, Hernandez-Herrera AC, Díaz-Giraldo J, Builes-Montano CE. Direct costs of severe hypoglycemia events in individuals with diabetes mellitus: A perspective from the Colombian health system – a single-center study. Hosp Pract (1995). 2025;53(1):2439775. PMID: 39648816. https://doi.org/10.1080/21548331.2024.2439775
  29. Петунина Н.А., Гончарова Е.В., Кузина И.А., Недосугова Л.В., Мартиросян Н.С., Тельнова М.Э. Роль пиоглитазона в борьбе с инсулинорезистентностью, атеросклерозом, сердечно-сосудистыми заболеваниями и неалкогольной жировой болезнью печени. Сахарный диабет. 2022;25(5):504–513. [Petunina NA, Goncharova EV, Kuzina IA, Nedosugova LV, Martirosyan NS, Теlnova MЕ. The role of pioglitazone in the fight against insulin resistance, atherosclerosis, cardiovascular disease, and non-alcoholic fatty liver disease. Sakharnyy diabet = Diabetes Mellitus. 2022;25(5):504–513 (In Russ.)]. EDN: SJPRER. https://doi.org/10.14341/dm12859
  30. Fayfman M, Galindo RJ, Rubin DJ, Mize DL, Anzola I, Urrutia MA et al. A randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes. Diabetes Care. 2019;42(3):450–56. PMID: 30679302. PMCID: PMC6905476. https://doi.org/10.2337/dc18-1760
  31. Fushimi N, Shibuya T, Yoshida Y, Ito S, Hachiya H, Mori A. Dulaglutide-combined basal plus correction insulin therapy contributes to ideal glycemic control in noncritical hospitalized patients. J Diabetes Investig. 2020;11(1):125–31. PMID: 31168938. PMCID: PMC6944833. https://doi. org/10.1111/jdi.13093
  32. Egede LE, Dismuke CE. Serious psychological distress and diabetes: A review of the literature. Curr Psychiatry Rep. 2012;14(1):15–22. PMID: 22002804. https://doi.org/10.1007/s11920-011-0240-0
  33. Абрамова А.Ю., Коплик Е.В., Алексеева И.В., Перцов С.С. Уровень глюкозы в крови крыс с разной поведенческой активностью в динамике многократных стрессорных воздействий. Российский медико-биологический вестник им. академика И.П. Павлова. 2019;27(1):10–19. [Abramova AYu, Koplik EV, Alekseeva IV, Pertsov SS. Blood glucose level in rats with different behavioral activity in the dynamics of repeated stress exposures. Rossiyskiy mediko-biologicheskiy vestnik imeni akademika IP Pavlova = IP Pavlov Russian Medical Biological Herald. 2019;27(1):10–19 (In Russ.)]. EDN: OMWZHD. https://doi.org/10.23888/pavlovj201927110-19
  34. Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK. Stress-induced hyperglycemia: Consequences and management. Cureus. 2022;14(7):e26714. PMID: 35959169. PMCID: PMC9360912. https://doi.org/10.7759/cureus.26714

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Bionika Media